Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,6.523665822393076e-30,inf,inf,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPLP0', 'RPL10A', 'RPL8', 'RPL9', 'RPL6', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL35', 'RPLP2', 'RPL38', 'RPL37', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS5', 'RPS6', 'RPL13A', 'RPSA', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL14', 'RPL13', 'RPS2', 'RPL15', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPL23A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",2.2898067036599698e-27,0,0,68
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,4.065120707705522e-15,33.98176291793313,1126.031010547066,"['NDUFB9', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB5', 'COX4I1', 'COX17', 'NDUFB3', 'ATP5MC2', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'SURF1', 'NDUFA7', 'ATP5PD', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'SLC25A5']",7.134286842023191e-13,0,0,40
3,Nonalcoholic fatty liver disease WP4396,8.51159620450999e-10,8.646525679758309,180.57768626058677,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB7', 'UQCRB', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'CYC1', 'NDUFA7', 'TGFB1', 'NDUFA6', 'NDUFA4', 'NDUFA1', 'NDUFC2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'CYCS', 'BAX']",9.958567559276688e-08,0,0,36
4,Oxidative phosphorylation WP623,6.565018913303004e-08,18.192307692307693,300.88121896321985,"['NDUFB9', 'ATP5PF', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'ATP5PD', 'ATP6AP1', 'NDUFB10', 'NDUFB5', 'NDUFA4', 'ATP6AP2', 'ATP5MC2', 'NDUFB2', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5MF', 'ATP5ME']",5.760804096423386e-06,0,0,22
5,Mitochondrial complex I assembly model OXPHOS system WP4324,5.361182553982175e-06,13.954478707782673,169.35610249917323,"['NDUFB9', 'NDUFA13', 'NDUFA7', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFB11', 'NDUFB5', 'NDUFB3', 'NDUFB2', 'NDUFA1', 'NDUFC2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'NDUFAF4']",0.0003191515740097743,0,0,17
6,Mitochondrial CIV Assembly WP4922,5.4555824617055434e-06,24.575402635431917,297.8261384560422,"['COA3', 'COX7B', 'SURF1', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'PET117', 'COX6B1', 'COX14', 'COX20']",0.0003191515740097743,0,0,15
7,Mitochondrial complex III assembly WP4921,0.00046056810313629113,inf,inf,"['UQCRB', 'UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'CYC1', 'UQCRH']",0.02309420060011974,0,0,8
8,Amino Acid metabolism WP3925,0.0012070830014885283,inf,inf,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'GSS', 'ODC1', 'SRM']",0.047076237058052604,0,0,7
9,Glycolysis and Gluconeogenesis WP534,0.0012070830014885283,inf,inf,"['LDHA', 'PKM', 'GOT1', 'MDH2', 'PGAM1', 'ALDOC', 'PFKM']",0.047076237058052604,0,0,7
10,Acute viral myocarditis WP4298,0.014882879753377015,9.702312138728324,40.82290266876838,"['ENDOG', 'CXADR', 'TGFB1', 'CYCS', 'BAX', 'EIF4G2']",0.5223890793435333,0,0,6
11,Pancreatic adenocarcinoma pathway WP4263,0.019355391205695516,5.662807525325615,22.338554123733896,"['TGFB1', 'CDK6', 'CDKN2A', 'PRKCD', 'BAX', 'PLD1', 'GADD45G']",0.617612937563557,0,0,7
12,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.021614138021117942,inf,inf,"['NDUFA13', 'HSP90AA1', 'RIPK2', 'AAMP']",0.6322135371176998,0,0,4
13,DNA IR-double strand breaks and cellular response via ATM WP3959,0.033810876325221735,8.073593073593074,27.345039682248263,"['DCLRE1C', 'PCNA', 'KAT5', 'CDKN2A', 'BAX']",0.9128936607809869,0,0,5
14,Cellular Proteostasis WP4918,0.05644572802634085,inf,inf,"['VBP1', 'PFDN5', 'PFDN6']",0.9746926686181449,0,0,3
15,Computational Model of Aerobic Glycolysis WP4629,0.05644572802634085,inf,inf,"['LDHA', 'PKM', 'PFKM']",0.9746926686181449,0,0,3
16,Glycolysis in senescence WP5049,0.05644572802634085,inf,inf,"['LDHA', 'PKM', 'ALDOC']",0.9746926686181449,0,0,3
17,Hair Follicle Development: Organogenesis - Part 2 of 3 WP2839,0.05644572802634085,inf,inf,"['FGF1', 'RUNX2', 'FGFR2']",0.9746926686181449,0,0,3
18,VEGFA-VEGFR2 Signaling Pathway WP3888,0.09573978876749394,1.5037697429970833,3.5280262263473827,"['SET', 'RPL10A', 'RPL7', 'SCUBE2', 'LDHA', 'RPL18A', 'TMSB4X', 'RPLP2', 'DNAJB9', 'ATP6V1E1', 'CCT7', 'HSP90AA1', 'SSR4', 'TRPC3', 'PRKCD', 'RPS6', 'RPL13A', 'RCN1', 'PTPN9', 'CYCS', 'RPL27', 'PRKD1', 'RPL26', 'EIF3D', 'EIF4G2']",0.9746926686181449,0,0,25
19,Cell cycle WP179,0.13060182727323078,2.2590448625180897,4.598516400319487,"['TGFB1', 'CDK6', 'PCNA', 'CDKN2A', 'CDC14B', 'ANAPC11', 'GADD45G']",0.9746926686181449,0,0,7
20,Serotonin and anxiety WP3947,0.14727825665010125,inf,inf,"['CRH', 'HTR2C']",0.9746926686181449,0,0,2
21,Serotonin and anxiety-related events WP3944,0.14727825665010125,inf,inf,"['CRH', 'HTR2C']",0.9746926686181449,0,0,2
22,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.14727825665010125,inf,inf,"['GSTP1', 'EPHX2']",0.9746926686181449,0,0,2
23,CAMKK2  Pathway WP4874,0.14727825665010125,inf,inf,"['FIS1', 'MAP1LC3A']",0.9746926686181449,0,0,2
24,Type II diabetes mellitus WP1584,0.14727825665010125,inf,inf,"['SURF1', 'PRKCD']",0.9746926686181449,0,0,2
25,Urea cycle and associated pathways WP4595,0.14727825665010125,inf,inf,"['GOT1', 'MDH2']",0.9746926686181449,0,0,2
26,Urea cycle and metabolism of amino groups WP497,0.14727825665010125,inf,inf,"['ODC1', 'SRM']",0.9746926686181449,0,0,2
27,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.14727825665010125,inf,inf,"['TGFB1', 'VIP']",0.9746926686181449,0,0,2
28,Cori Cycle WP1946,0.14727825665010125,inf,inf,"['LDHA', 'PGAM1']",0.9746926686181449,0,0,2
29,Wnt Signaling Pathway WP363,0.14727825665010125,inf,inf,"['CDK6', 'ROR2']",0.9746926686181449,0,0,2
30,Dual hijack model of Vif in HIV infection WP3300,0.14727825665010125,inf,inf,"['ELOB', 'RUNX1']",0.9746926686181449,0,0,2
31,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.14727825665010125,inf,inf,"['H3F3B', 'H2AFZ']",0.9746926686181449,0,0,2
32,Gastric acid production WP2596,0.14727825665010125,inf,inf,"['CCK', 'VIP']",0.9746926686181449,0,0,2
33,Glutathione metabolism WP100,0.14727825665010125,inf,inf,"['GPX4', 'GSS']",0.9746926686181449,0,0,2
34,Histone Modifications WP2369,0.14727825665010125,inf,inf,"['SET', 'H3F3B']",0.9746926686181449,0,0,2
35,Mammary gland development pathway - Embryonic development (Stage 1 of 4) WP2813,0.14727825665010125,inf,inf,"['SFRP1', 'TGFB1']",0.9746926686181449,0,0,2
36,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.14727825665010125,inf,inf,"['GOT1', 'MDH2']",0.9746926686181449,0,0,2
37,NO/cGMP/PKG mediated Neuroprotection WP4008,0.14727825665010125,inf,inf,"['PDE3A', 'CYCS']",0.9746926686181449,0,0,2
38,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.14727825665010125,inf,inf,"['TGFB1', 'BAX']",0.9746926686181449,0,0,2
39,miRNA regulation of DNA damage response WP1530,0.14929345142586203,2.6863876863876865,5.109083418486237,"['CDK6', 'CCNG1', 'CYCS', 'BAX', 'GADD45G']",0.9746926686181449,0,0,5
40,Modulators of TCR signaling and T cell activation WP5072,0.14929345142586203,2.6863876863876865,5.109083418486237,"['FIBP', 'NDUFB10', 'ELOB', 'LCP2', 'RNF7']",0.9746926686181449,0,0,5
41,Non-small cell lung cancer WP4255,0.14929345142586203,2.6863876863876865,5.109083418486237,"['CDK6', 'CDKN2A', 'CYCS', 'BAX', 'GADD45G']",0.9746926686181449,0,0,5
42,16p11.2 proximal deletion syndrome WP4949,0.15736132903216896,3.2219020172910664,5.957975553047508,"['PCNA', 'ASPHD1', 'SEZ6L2', 'CCT7']",0.9746926686181449,0,0,4
43,Base Excision Repair WP4752,0.15736132903216896,3.2219020172910664,5.957975553047508,"['POLE4', 'PCNA', 'NEIL2', 'APEX1']",0.9746926686181449,0,0,4
44,Corticotropin-releasing hormone signaling pathway WP2355,0.15736132903216896,3.2219020172910664,5.957975553047508,"['HSP90AA1', 'TGFB1', 'PRKCD', 'CRH']",0.9746926686181449,0,0,4
45,Metabolic reprogramming in colon cancer WP4290,0.15736132903216896,3.2219020172910664,5.957975553047508,"['LDHA', 'PKM', 'MDH2', 'PGAM1']",0.9746926686181449,0,0,4
46,Prader-Willi and Angelman Syndrome WP3998,0.15736132903216896,3.2219020172910664,5.957975553047508,"['CDK6', 'CDKN2A', 'HTR2C', 'GABRD']",0.9746926686181449,0,0,4
47,Cardiac Hypertrophic Response WP2795,0.16094052340621062,4.8302158273381295,8.823453798283031,"['TGFB1', 'PRKD1', 'FGFR2']",0.9746926686181449,0,0,3
48,Type 2 papillary renal cell carcinoma WP4241,0.16094052340621062,4.8302158273381295,8.823453798283031,"['TGFB1', 'COL21A1', 'ELOB']",0.9746926686181449,0,0,3
49,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.16094052340621062,4.8302158273381295,8.823453798283031,"['MAP1LC3A', 'IGFBP5', 'PLD1']",0.9746926686181449,0,0,3
50,Nanomaterial induced apoptosis WP2507,0.16094052340621062,4.8302158273381295,8.823453798283031,"['ENDOG', 'BAX', 'CYCS']",0.9746926686181449,0,0,3
51,Nucleotide metabolism WP404,0.16094052340621062,4.8302158273381295,8.823453798283031,"['NME2', 'OAZ1', 'SRM']",0.9746926686181449,0,0,3
52,Melanoma WP4685,0.23342338115380595,2.012987012987013,2.9286975988663286,"['CDK6', 'CDKN2A', 'KIT', 'BAX', 'GADD45G']",0.9746926686181449,0,0,5
53,Proteasome Degradation WP183,0.23342338115380595,2.012987012987013,2.9286975988663286,"['PSMB6', 'PSMC5', 'H2AFZ', 'HLA-B', 'PSMB10']",0.9746926686181449,0,0,5
54,DNA damage response WP707,0.25900186974375333,2.1460134486071087,2.8990924841741412,"['CDK6', 'CYCS', 'BAX', 'GADD45G']",0.9746926686181449,0,0,4
55,Selenium Micronutrient Network WP15,0.2638484530183724,1.6107091172214183,2.146077229309683,"['SELENOM', 'GPX4', 'SELENOS', 'SELENOW', 'SELENOK', 'SEPHS2', 'SELENOH']",0.9746926686181449,0,0,7
56,DNA Repair Pathways Full Network WP4946,0.2638484530183724,1.6107091172214183,2.146077229309683,"['FANCI', 'POLE4', 'DCLRE1C', 'NEIL2', 'PCNA', 'CENPX', 'APEX1']",0.9746926686181449,0,0,7
57,TP53 network WP1742,0.28985975555654514,2.4129496402877697,2.988095670421171,"['SUMO1', 'CDKN2A', 'BAX']",0.9746926686181449,0,0,3
58,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.28985975555654514,2.4129496402877697,2.988095670421171,"['PRKCD', 'RPS6', 'PIM1']",0.9746926686181449,0,0,3
59,Tumor suppressor activity of SMARCB1 WP4204,0.28985975555654514,2.4129496402877697,2.988095670421171,"['CDK6', 'H3F3B', 'CDKN2A']",0.9746926686181449,0,0,3
60,Glycosylation and related congenital defects WP4521,0.28985975555654514,2.4129496402877697,2.988095670421171,"['DPM2', 'DPM3', 'MAGT1']",0.9746926686181449,0,0,3
61,Interleukin-11 Signaling Pathway WP2332,0.28985975555654514,2.4129496402877697,2.988095670421171,"['TGFB1', 'RPS6', 'RUNX2']",0.9746926686181449,0,0,3
62,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.28985975555654514,2.4129496402877697,2.988095670421171,"['HSP90AA1', 'CDKN2A', 'BAX']",0.9746926686181449,0,0,3
63,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.28985975555654514,2.4129496402877697,2.988095670421171,"['LDHA', 'PKM', 'BAX']",0.9746926686181449,0,0,3
64,Pregnane X receptor pathway WP2876,0.28985975555654514,2.4129496402877697,2.988095670421171,"['HSP90AA1', 'PSMC5', 'CYP3A5']",0.9746926686181449,0,0,3
65,Rett syndrome causing genes WP4312,0.28985975555654514,2.4129496402877697,2.988095670421171,"['IMPDH2', 'HAP1', 'GABRD']",0.9746926686181449,0,0,3
66,Apoptosis Modulation and Signaling WP1772,0.2926341480851838,1.6098265895953756,1.9782065750684654,"['HRK', 'ENDOG', 'CDKN2A', 'CYCS', 'BAX', 'PRKD1']",0.9746926686181449,0,0,6
67,Gastrin signaling pathway WP4659,0.2926341480851838,1.6098265895953756,1.9782065750684654,"['KAT5', 'CDKN2A', 'RPS6', 'PRKCD', 'KIT', 'PRKD1']",0.9746926686181449,0,0,6
68,7q11.23 copy number variation syndrome WP4932,0.3268452958054645,1.608946608946609,1.799234023842332,"['PCNA', 'ATP5MC2', 'GTF2IRD1', 'ATP5F1E', 'ATP5MC1']",0.9746926686181449,0,0,5
69,Pathways in clear cell renal cell carcinoma WP4018,0.3268452958054645,1.608946608946609,1.799234023842332,"['LDHA', 'PKM', 'TGFB1', 'ALDOC', 'PFKM']",0.9746926686181449,0,0,5
70,ACE Inhibitor Pathway WP554,0.32894320007609784,3.2155172413793105,3.57523775733294,"['TGFB1', 'ATP6AP2']",0.9746926686181449,0,0,2
71,Amyotrophic lateral sclerosis (ALS) WP2447,0.32894320007609784,3.2155172413793105,3.57523775733294,"['TOMM40', 'BAX']",0.9746926686181449,0,0,2
72,Type II interferon signaling (IFNG) WP619,0.32894320007609784,3.2155172413793105,3.57523775733294,"['PRKCD', 'HLA-B']",0.9746926686181449,0,0,2
73,Cysteine and methionine catabolism WP4504,0.32894320007609784,3.2155172413793105,3.57523775733294,"['GOT1', 'GSS']",0.9746926686181449,0,0,2
74,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.32894320007609784,3.2155172413793105,3.57523775733294,"['RPS6', 'SGK1']",0.9746926686181449,0,0,2
75,Hematopoietic Stem Cell Differentiation WP2849,0.32894320007609784,3.2155172413793105,3.57523775733294,"['PIM1', 'RUNX1']",0.9746926686181449,0,0,2
76,MAP3K1 role in promoting and blocking gonadal determination WP4872,0.32894320007609784,3.2155172413793105,3.57523775733294,"['FGFR2', 'GADD45G']",0.9746926686181449,0,0,2
77,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.32894320007609784,3.2155172413793105,3.57523775733294,"['MAP1LC3A', 'FTL']",0.9746926686181449,0,0,2
78,nsp1 from SARS-CoV-2 inhibits translation initiation in the host cell WP5027,0.32894320007609784,3.2155172413793105,3.57523775733294,"['EIF3I', 'EIF3D']",0.9746926686181449,0,0,2
79,Oxidation by Cytochrome P450 WP43,0.32894320007609784,3.2155172413793105,3.57523775733294,"['CYB5R1', 'CYP3A5']",0.9746926686181449,0,0,2
80,22q11.2 copy number variation syndrome WP4657,0.36871025506075633,1.6080691642651297,1.6044416175588965,"['RANBP1', 'MRPL40', 'DGCR6L', 'FGFR2']",0.9746926686181449,0,0,4
81,Apoptosis WP254,0.36871025506075633,1.6080691642651297,1.6044416175588965,"['HRK', 'CDKN2A', 'CYCS', 'BAX']",0.9746926686181449,0,0,4
82,Aryl Hydrocarbon Receptor Pathway WP2873,0.36871025506075633,1.6080691642651297,1.6044416175588965,"['HSP90AA1', 'TGFB1', 'AIP', 'BAX']",0.9746926686181449,0,0,4
83,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.36871025506075633,1.6080691642651297,1.6044416175588965,"['TGFB1', 'CYCS', 'BAX', 'GADD45G']",0.9746926686181449,0,0,4
84,Endometrial cancer WP4155,0.36871025506075633,1.6080691642651297,1.6044416175588965,"['BAX', 'FGF1', 'FGFR2', 'GADD45G']",0.9746926686181449,0,0,4
85,Ciliary landscape WP4352,0.3809532130622562,1.2869565217391303,1.2420143420879775,"['VPS4A', 'CD2BP2', 'COPS7A', 'MYL6B', 'WDR34', 'COX6C', 'DCAF11', 'LSM4']",0.9746926686181449,0,0,8
86,15q11.2 copy number variation syndrome WP4940,0.38393822607524536,inf,inf,['TUBGCP4'],0.9746926686181449,0,0,1
87,Selective expression of chemokine receptors during T-cell polarization WP4494,0.38393822607524536,inf,inf,['TGFB1'],0.9746926686181449,0,0,1
88,16p11.2 distal deletion syndrome WP4950,0.38393822607524536,inf,inf,['CD81'],0.9746926686181449,0,0,1
89,ApoE and miR-146 in inflammation and atherosclerosis WP3926,0.38393822607524536,inf,inf,['APOE'],0.9746926686181449,0,0,1
90,Apoptosis Modulation by HSP70 WP384,0.38393822607524536,inf,inf,['CYCS'],0.9746926686181449,0,0,1
91,Tamoxifen metabolism WP691,0.38393822607524536,inf,inf,['CYP3A5'],0.9746926686181449,0,0,1
92,TCA cycle in senescence WP5050,0.38393822607524536,inf,inf,['GOT1'],0.9746926686181449,0,0,1
93,TFs regulate miRNAs related to cardiac hypertrophy WP1559,0.38393822607524536,inf,inf,['TGFB1'],0.9746926686181449,0,0,1
94,Biomarkers for urea cycle disorders WP4583,0.38393822607524536,inf,inf,['GOT1'],0.9746926686181449,0,0,1
95,Thiamine metabolic pathways WP4297,0.38393822607524536,inf,inf,['BCKDK'],0.9746926686181449,0,0,1
96,Bone morphogenic protein (BMP) signaling and regulation WP1425,0.38393822607524536,inf,inf,['RUNX2'],0.9746926686181449,0,0,1
97,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.38393822607524536,inf,inf,['RPS6'],0.9746926686181449,0,0,1
98,Canonical and non-canonical TGF-B signaling WP3874,0.38393822607524536,inf,inf,['TGFB1'],0.9746926686181449,0,0,1
99,"Cerebral organic acidurias, including diseases WP4519",0.38393822607524536,inf,inf,['MDH2'],0.9746926686181449,0,0,1
100,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.38393822607524536,inf,inf,['RPH3AL'],0.9746926686181449,0,0,1
101,Disruption of postsynaptic signaling by CNV WP4875,0.38393822607524536,inf,inf,['SHANK1'],0.9746926686181449,0,0,1
102,Ebstein-Barr virus LMP1 signaling WP262,0.38393822607524536,inf,inf,['HSP90AA1'],0.9746926686181449,0,0,1
103,Effect of progerin on genes involved in Hutchinson-Gilford progeria syndrome WP4320,0.38393822607524536,inf,inf,['H3F3B'],0.9746926686181449,0,0,1
104,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.38393822607524536,inf,inf,['EPHX2'],0.9746926686181449,0,0,1
105,EV release from cardiac cells and their functional effects WP3297,0.38393822607524536,inf,inf,['RGS16'],0.9746926686181449,0,0,1
106,"Gamma-glutamyl cycle for the biosynthesis and degradation of glutathione, including diseases WP4518",0.38393822607524536,inf,inf,['GSS'],0.9746926686181449,0,0,1
107,"GPCRs, Class C Metabotropic glutamate, pheromone WP501",0.38393822607524536,inf,inf,['GABBR1'],0.9746926686181449,0,0,1
108,HIF1A and PPARG regulation of glycolysis WP2456,0.38393822607524536,inf,inf,['LDHA'],0.9746926686181449,0,0,1
109,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.38393822607524536,inf,inf,['ELOB'],0.9746926686181449,0,0,1
110,Host-pathogen interaction of human coronaviruses - autophagy WP4863,0.38393822607524536,inf,inf,['MAP1LC3A'],0.9746926686181449,0,0,1
111,Insulin signaling in adipocytes (diabetic condition) WP3635,0.38393822607524536,inf,inf,['RPS6'],0.9746926686181449,0,0,1
112,Insulin signaling in adipocytes (normal condition) WP3634,0.38393822607524536,inf,inf,['RPS6'],0.9746926686181449,0,0,1
113,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.38393822607524536,inf,inf,['TGFB1'],0.9746926686181449,0,0,1
114,Irinotecan pathway WP229,0.38393822607524536,inf,inf,['CYP3A5'],0.9746926686181449,0,0,1
115,Linoleic acid metabolism known to be affected by coronavirus infection WP4853,0.38393822607524536,inf,inf,['ACOT2'],0.9746926686181449,0,0,1
116,mBDNF and proBDNF regulation of GABA neurotransmission WP4829,0.38393822607524536,inf,inf,['GABRD'],0.9746926686181449,0,0,1
117,Metastatic brain tumor WP2249,0.38393822607524536,inf,inf,['CDK6'],0.9746926686181449,0,0,1
118,Mitochondrial fatty acid synthesis pathway WP4317,0.38393822607524536,inf,inf,['HSD17B12'],0.9746926686181449,0,0,1
119,NAD+ metabolism WP3644,0.38393822607524536,inf,inf,['NMNAT1'],0.9746926686181449,0,0,1
120,Nanoparticle triggered autophagic cell death WP2509,0.38393822607524536,inf,inf,['MAP1LC3A'],0.9746926686181449,0,0,1
121,Nanoparticle triggered regulated necrosis WP2513,0.38393822607524536,inf,inf,['FTL'],0.9746926686181449,0,0,1
122,Non-homologous end joining WP438,0.38393822607524536,inf,inf,['DCLRE1C'],0.9746926686181449,0,0,1
123,Omega-3/Omega-6 FA synthesis WP4723,0.38393822607524536,inf,inf,['ACOT2'],0.9746926686181449,0,0,1
124,Peroxiredoxin 2 induced ovarian failure WP4873,0.38393822607524536,inf,inf,['BAX'],0.9746926686181449,0,0,1
125,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.38393822607524536,inf,inf,['LDHA'],0.9746926686181449,0,0,1
126,Platelet-mediated interactions with vascular and circulating cells WP4462,0.38393822607524536,inf,inf,['TGFB1'],0.9746926686181449,0,0,1
127,Role of Osx and miRNAs in tooth development WP3971,0.38393822607524536,inf,inf,['RUNX2'],0.9746926686181449,0,0,1
128,MAPK Signaling Pathway WP382,0.4196565464784932,1.2505225920566008,1.08585208733035,"['DUSP4', 'TGFB1', 'DDIT3', 'RASGRF2', 'PRKCD', 'FGF1', 'FGFR2']",0.9746926686181449,0,0,7
129,Alzheimer's disease WP2059,0.42235812131051176,1.6071942446043166,1.3852434454347926,"['ATP5MD', 'CYCS', 'APOE']",0.9746926686181449,0,0,3
130,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.42235812131051176,1.6071942446043166,1.3852434454347926,"['APEX1', 'RPS6', 'PLD1']",0.9746926686181449,0,0,3
131,Differentiation Pathway WP2848,0.42235812131051176,1.6071942446043166,1.3852434454347926,"['TGFB1', 'KIT', 'FGF1']",0.9746926686181449,0,0,3
132,GABA receptor Signaling WP4159,0.42235812131051176,1.6071942446043166,1.3852434454347926,"['GABBR1', 'SLC32A1', 'GABRD']",0.9746926686181449,0,0,3
133,One-carbon metabolism and related pathways WP3940,0.42235812131051176,1.6071942446043166,1.3852434454347926,"['GPX4', 'GSS', 'PLD1']",0.9746926686181449,0,0,3
134,Peptide GPCRs WP24,0.42235812131051176,1.6071942446043166,1.3852434454347926,"['MC1R', 'ACKR1', 'HCRTR2']",0.9746926686181449,0,0,3
135,Ferroptosis WP4313,0.4228680130059764,1.3395863395863397,1.1529754984644063,"['MAP1LC3A', 'GPX4', 'GSS', 'SAT2', 'FTL']",0.9746926686181449,0,0,5
136,Hepatitis B infection WP4666,0.4228680130059764,1.3395863395863397,1.1529754984644063,"['TGFB1', 'PCNA', 'ATP6AP1', 'CYCS', 'BAX']",0.9746926686181449,0,0,5
137,Metapathway biotransformation Phase I and II WP702,0.4228680130059764,1.3395863395863397,1.1529754984644063,"['GPX4', 'EPHX2', 'GSTP1', 'GSS', 'CYP3A5']",0.9746926686181449,0,0,5
138,Osteoblast differentiation WP4787,0.4228680130059764,1.3395863395863397,1.1529754984644063,"['PRKCD', 'PRKD1', 'FGF1', 'RUNX2', 'FGFR2']",0.9746926686181449,0,0,5
139,IL-18 signaling pathway WP4754,0.4633267361770371,1.0997310795236266,0.8460481714545662,"['TOMM40', 'USP5', 'CD81', 'RGS16', 'PRKCD', 'COX17', 'NDUFC1', 'PLD1', 'RUNX2', 'TMSB4X', 'SYT10', 'CYCS', 'BAX']",0.9746926686181449,0,0,13
140,Pyrimidine metabolism WP4022,0.46414366464498774,1.2052023121387283,0.9250664758204126,"['POLE4', 'NME2', 'NME3', 'POLR2I', 'POLR2K', 'POLR2L']",0.9746926686181449,0,0,6
141,Small cell lung cancer WP4658,0.4769397012131694,1.2853025936599423,0.9515933229148481,"['CDK6', 'CYCS', 'BAX', 'GADD45G']",0.9746926686181449,0,0,4
142,T-cell receptor (TCR) signaling pathway WP69,0.4769397012131694,1.2853025936599423,0.9515933229148481,"['TGFB1', 'RIPK2', 'PRKCD', 'LCP2']",0.9746926686181449,0,0,4
143,Endoderm differentiation WP2853,0.4769397012131694,1.2853025936599423,0.9515933229148481,"['DUSP4', 'SFRP1', 'TGFB1', 'TCEAL2']",0.9746926686181449,0,0,4
144,Sleep regulation WP3591,0.49694575097776406,1.6063218390804597,1.1232597591931115,"['CRH', 'HCRTR2']",0.9746926686181449,0,0,2
145,ATM Signaling Network in Development and Disease  WP3878,0.49694575097776406,1.6063218390804597,1.1232597591931115,"['DCLRE1C', 'KAT5']",0.9746926686181449,0,0,2
146,TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859,0.49694575097776406,1.6063218390804597,1.1232597591931115,"['TGFB1', 'RUNX2']",0.9746926686181449,0,0,2
147,BMP Signaling Pathway in Eyelid Development WP3927,0.49694575097776406,1.6063218390804597,1.1232597591931115,"['SFRP1', 'FGFR2']",0.9746926686181449,0,0,2
148,Constitutive Androstane Receptor Pathway WP2875,0.49694575097776406,1.6063218390804597,1.1232597591931115,"['HSP90AA1', 'CYP3A5']",0.9746926686181449,0,0,2
149,Cytosolic DNA-sensing pathway WP4655,0.49694575097776406,1.6063218390804597,1.1232597591931115,"['POLR2K', 'POLR2L']",0.9746926686181449,0,0,2
150,Fas ligand pathway and stress induction of heat shock proteins WP314,0.49694575097776406,1.6063218390804597,1.1232597591931115,"['RIPK2', 'CYCS']",0.9746926686181449,0,0,2
151,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.49694575097776406,1.6063218390804597,1.1232597591931115,"['IFITM3', 'DDIT3']",0.9746926686181449,0,0,2
152,Methionine De Novo and Salvage Pathway WP3580,0.49694575097776406,1.6063218390804597,1.1232597591931115,"['ODC1', 'SRM']",0.9746926686181449,0,0,2
153,Neovascularisation processes WP4331,0.49694575097776406,1.6063218390804597,1.1232597591931115,"['TGFB1', 'KIT']",0.9746926686181449,0,0,2
154,Oxidative Damage WP3941,0.49694575097776406,1.6063218390804597,1.1232597591931115,"['PCNA', 'CYCS']",0.9746926686181449,0,0,2
155,Ectoderm Differentiation WP2858,0.5158921529804291,1.147186147186147,0.7592738026721386,"['PIM1', 'ROR2', 'NR2F2', 'JAKMIP1', 'FGFR2']",0.9746926686181449,0,0,5
156,Synaptic Vesicle Pathway WP2267,0.5448752295755458,1.20431654676259,0.7312591369960239,"['SLC32A1', 'PARK7', 'CPLX3']",0.9746926686181449,0,0,3
157,Translation Factors WP107,0.5448752295755458,1.20431654676259,0.7312591369960239,"['EEF1B2', 'EIF3I', 'EIF3D']",0.9746926686181449,0,0,3
158,Eukaryotic Transcription Initiation WP405,0.5448752295755458,1.20431654676259,0.7312591369960239,"['TAF13', 'POLR2I', 'POLR2K']",0.9746926686181449,0,0,3
159,Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864,0.5770025710939355,1.0701248799231509,0.5884708280096197,"['BEX3', 'RIPK2', 'RNF7', 'APOE']",0.9746926686181449,0,0,4
160,Exercise-induced Circadian Regulation WP410,0.5770025710939355,1.0701248799231509,0.5884708280096197,"['DAZAP2', 'SUMO1', 'GSTP1', 'EIF4G2']",0.9746926686181449,0,0,4
161,Glioblastoma signaling pathways WP2261,0.5770025710939355,1.0701248799231509,0.5884708280096197,"['CDK6', 'CDKN2A', 'PRKCD', 'FGFR2']",0.9746926686181449,0,0,4
162,Proximal tubule transport WP4917,0.5770025710939355,1.0701248799231509,0.5884708280096197,"['ATP6V1G1', 'ATP6V1E1', 'ATP6V1D', 'ATP6V1F']",0.9746926686181449,0,0,4
163,Androgen receptor signaling pathway WP138,0.6018853887036328,1.002886002886003,0.5091534257262456,"['SUMO1', 'KAT5', 'STUB1', 'PARK7', 'RUNX2']",0.9746926686181449,0,0,5
164,EGF/EGFR signaling pathway WP437,0.6018853887036328,1.002886002886003,0.5091534257262456,"['NDUFA13', 'PCNA', 'PRKCD', 'NEDD8', 'PLD1']",0.9746926686181449,0,0,5
165,mRNA Processing WP411,0.6018853887036328,1.002886002886003,0.5091534257262456,"['SF3B5', 'LSM7', 'SF3A1', 'CD2BP2', 'SRSF9']",0.9746926686181449,0,0,5
166,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.62059788944251,1.60545193687231,0.7659160505259486,['HTR2C'],0.9746926686181449,0,0,1
167,Signal transduction through IL1R WP4496,0.62059788944251,1.60545193687231,0.7659160505259486,['TGFB1'],0.9746926686181449,0,0,1
168,T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863,0.62059788944251,1.60545193687231,0.7659160505259486,['LCP2'],0.9746926686181449,0,0,1
169,TCA Cycle (aka Krebs or citric acid cycle) WP78,0.62059788944251,1.60545193687231,0.7659160505259486,['MDH2'],0.9746926686181449,0,0,1
170,Trans-sulfuration and one-carbon metabolism WP2525,0.62059788944251,1.60545193687231,0.7659160505259486,['GSS'],0.9746926686181449,0,0,1
171,Trans-sulfuration pathway WP2333,0.62059788944251,1.60545193687231,0.7659160505259486,['GOT1'],0.9746926686181449,0,0,1
172,Transcription co-factors SKI and SKIL protein partners WP4533,0.62059788944251,1.60545193687231,0.7659160505259486,['MERTK'],0.9746926686181449,0,0,1
173,Transcriptional cascade regulating adipogenesis WP4211,0.62059788944251,1.60545193687231,0.7659160505259486,['DDIT3'],0.9746926686181449,0,0,1
174,Cell Differentiation - Index expanded WP2023,0.62059788944251,1.60545193687231,0.7659160505259486,['RUNX2'],0.9746926686181449,0,0,1
175,Tryptophan catabolism leading to NAD+ production WP4210,0.62059788944251,1.60545193687231,0.7659160505259486,['NMNAT1'],0.9746926686181449,0,0,1
176,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.62059788944251,1.60545193687231,0.7659160505259486,['CCK'],0.9746926686181449,0,0,1
177,Composition of Lipid Particles WP3601,0.62059788944251,1.60545193687231,0.7659160505259486,['APOE'],0.9746926686181449,0,0,1
178,Cytokines and Inflammatory Response WP530,0.62059788944251,1.60545193687231,0.7659160505259486,['TGFB1'],0.9746926686181449,0,0,1
179,Development of pulmonary dendritic cells and macrophage subsets WP3892,0.62059788944251,1.60545193687231,0.7659160505259486,['RUNX2'],0.9746926686181449,0,0,1
180,Dopaminergic Neurogenesis WP2855,0.62059788944251,1.60545193687231,0.7659160505259486,['TGFB1'],0.9746926686181449,0,0,1
181,Globo Sphingolipid Metabolism WP1424,0.62059788944251,1.60545193687231,0.7659160505259486,['ST6GAL1'],0.9746926686181449,0,0,1
182,Glycerolipids and Glycerophospholipids WP4722,0.62059788944251,1.60545193687231,0.7659160505259486,['PLD1'],0.9746926686181449,0,0,1
183,Heart Development WP1591,0.62059788944251,1.60545193687231,0.7659160505259486,['VEGFB'],0.9746926686181449,0,0,1
184,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.62059788944251,1.60545193687231,0.7659160505259486,['BAX'],0.9746926686181449,0,0,1
185,Interferon type I signaling pathways WP585,0.62059788944251,1.60545193687231,0.7659160505259486,['RPS6'],0.9746926686181449,0,0,1
186,Intraflagellar transport proteins binding to dynein WP4532,0.62059788944251,1.60545193687231,0.7659160505259486,['WDR34'],0.9746926686181449,0,0,1
187,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.62059788944251,1.60545193687231,0.7659160505259486,['BAX'],0.9746926686181449,0,0,1
188,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.62059788944251,1.60545193687231,0.7659160505259486,['APOE'],0.9746926686181449,0,0,1
189,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.62059788944251,1.60545193687231,0.7659160505259486,['VEGFB'],0.9746926686181449,0,0,1
190,miRNA regulation of p53 pathway in prostate cancer WP3982,0.62059788944251,1.60545193687231,0.7659160505259486,['BAX'],0.9746926686181449,0,0,1
191,miRNAs involved in DNA damage response WP1545,0.62059788944251,1.60545193687231,0.7659160505259486,['CDK6'],0.9746926686181449,0,0,1
192,MTHFR deficiency WP4288,0.62059788944251,1.60545193687231,0.7659160505259486,['CYCS'],0.9746926686181449,0,0,1
193,NAD Biosynthesis II (from tryptophan) WP2485,0.62059788944251,1.60545193687231,0.7659160505259486,['NMNAT1'],0.9746926686181449,0,0,1
194,NAD+ biosynthetic pathways WP3645,0.62059788944251,1.60545193687231,0.7659160505259486,['NMNAT1'],0.9746926686181449,0,0,1
195,Osteoclast Signaling WP12,0.62059788944251,1.60545193687231,0.7659160505259486,['ATP6V1G1'],0.9746926686181449,0,0,1
196,Overview of nanoparticle effects WP3287,0.62059788944251,1.60545193687231,0.7659160505259486,['BAX'],0.9746926686181449,0,0,1
197,PKC-gamma calcium signaling pathway in ataxia WP4760,0.62059788944251,1.60545193687231,0.7659160505259486,['TRPC3'],0.9746926686181449,0,0,1
198,Purinergic signaling WP4900,0.62059788944251,1.60545193687231,0.7659160505259486,['P2RY14'],0.9746926686181449,0,0,1
199,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.62059788944251,1.60545193687231,0.7659160505259486,['ANAPC11'],0.9746926686181449,0,0,1
200,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.62059788944251,1.60545193687231,0.7659160505259486,['TGFB1'],0.9746926686181449,0,0,1
201,SARS-CoV-2 mitochondrial interactions WP5038,0.62059788944251,1.60545193687231,0.7659160505259486,['NDUFB9'],0.9746926686181449,0,0,1
202,3q29 copy number variation syndrome WP4906,0.6350029518052538,1.0699233716475096,0.4858796269002295,"['TGFB1', 'WDR34']",0.9746926686181449,0,0,2
203,AGE/RAGE pathway WP2324,0.6350029518052538,1.0699233716475096,0.4858796269002295,"['PRKCD', 'CYCS']",0.9746926686181449,0,0,2
204,The influence of laminopathies on Wnt signaling WP4844,0.6350029518052538,1.0699233716475096,0.4858796269002295,"['CDK6', 'RUNX2']",0.9746926686181449,0,0,2
205,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.6350029518052538,1.0699233716475096,0.4858796269002295,"['SFRP1', 'SST']",0.9746926686181449,0,0,2
206,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.6350029518052538,1.0699233716475096,0.4858796269002295,"['NPY', 'RPS6']",0.9746926686181449,0,0,2
207,TNF-alpha signaling pathway WP231,0.6350029518052538,1.0699233716475096,0.4858796269002295,"['HSP90AA1', 'BAX']",0.9746926686181449,0,0,2
208,White fat cell differentiation WP4149,0.6350029518052538,1.0699233716475096,0.4858796269002295,"['DDIT3', 'NR2F2']",0.9746926686181449,0,0,2
209,Zinc homeostasis WP3529,0.6350029518052538,1.0699233716475096,0.4858796269002295,"['SLC39A11', 'SLC39A7']",0.9746926686181449,0,0,2
210,DNA Mismatch Repair WP531,0.6350029518052538,1.0699233716475096,0.4858796269002295,"['POLE4', 'PCNA']",0.9746926686181449,0,0,2
211,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.6350029518052538,1.0699233716475096,0.4858796269002295,"['LDHA', 'RPS6']",0.9746926686181449,0,0,2
212,Kit receptor signaling pathway WP304,0.6350029518052538,1.0699233716475096,0.4858796269002295,"['RPS6', 'KIT']",0.9746926686181449,0,0,2
213,Parkinson's disease pathway WP2371,0.6350029518052538,1.0699233716475096,0.4858796269002295,"['CYCS', 'PARK7']",0.9746926686181449,0,0,2
214,Regulation of toll-like receptor signaling pathway WP1449,0.6350029518052538,1.0699233716475096,0.4858796269002295,"['CUEDC2', 'PELI3']",0.9746926686181449,0,0,2
215,Cardiac Progenitor Differentiation WP2406,0.650574121804583,0.962589928057554,0.4138174501408008,"['TGFB1', 'KIT', 'ROR2']",0.9746926686181449,0,0,3
216,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.650574121804583,0.962589928057554,0.4138174501408008,"['PPP1R14A', 'MAP1LC3A', 'DDIT3']",0.9746926686181449,0,0,3
217,Fragile X Syndrome  WP4549,0.650574121804583,0.962589928057554,0.4138174501408008,"['CDKN2A', 'GABRD', 'SHANK1']",0.9746926686181449,0,0,3
218,G1 to S cell cycle control WP45,0.650574121804583,0.962589928057554,0.4138174501408008,"['PCNA', 'CDK6', 'CDKN2A']",0.9746926686181449,0,0,3
219,MECP2 and Associated Rett Syndrome WP3584,0.650574121804583,0.962589928057554,0.4138174501408008,"['SST', 'RPS6', 'SGK1']",0.9746926686181449,0,0,3
220,Retinoblastoma gene in cancer WP2446,0.650574121804583,0.962589928057554,0.4138174501408008,"['PCNA', 'CDK6', 'H2AFZ']",0.9746926686181449,0,0,3
221,TGF-beta Signaling Pathway WP366,0.6650793846408292,0.9164265129682997,0.37376351779909694,"['TGFB1', 'PARD6A', 'SUMO1', 'RUNX2']",0.9746926686181449,0,0,4
222,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.6650793846408292,0.9164265129682997,0.37376351779909694,"['RPS6', 'PDGFC', 'BAX', 'FGFR2']",0.9746926686181449,0,0,4
223,Head and Neck Squamous Cell Carcinoma WP4674,0.6650793846408292,0.9164265129682997,0.37376351779909694,"['CDK6', 'CDKN2A', 'RPS6', 'FGFR2']",0.9746926686181449,0,0,4
224,Breast cancer pathway WP4262,0.678408501462861,0.890652557319224,0.34557823595674336,"['CDK6', 'KIT', 'BAX', 'FGF1', 'GADD45G']",0.9746926686181449,0,0,5
225,Integrated breast cancer pathway WP1984,0.678408501462861,0.890652557319224,0.34557823595674336,"['DCAKD', 'ODC1', 'BAX', 'FAU', 'JAKMIP1']",0.9746926686181449,0,0,5
226,Allograft Rejection WP2328,0.7373912320260567,0.8014388489208633,0.24414767307813043,"['TGFB1', 'COL5A1', 'HLA-B']",0.9746926686181449,0,0,3
227,Spinal Cord Injury WP2431,0.7396729169052527,0.8011527377521613,0.24158536057828847,"['TGFB1', 'APEX1', 'CCNG1', 'OMG']",0.9746926686181449,0,0,4
228,7-oxo-C and 7beta-HC pathways WP5064,0.7413252351369617,0.8017241379310345,0.23996873071887626,"['EPHX2', 'ACOT2']",0.9746926686181449,0,0,2
229,Aryl Hydrocarbon Receptor Netpath WP2586,0.7413252351369617,0.8017241379310345,0.23996873071887626,"['HSP90AA1', 'AIP']",0.9746926686181449,0,0,2
230,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.7413252351369617,0.8017241379310345,0.23996873071887626,"['TGFB1', 'RUNX2']",0.9746926686181449,0,0,2
231,TGF-beta Receptor Signaling WP560,0.7413252351369617,0.8017241379310345,0.23996873071887626,"['TGFB1', 'RUNX2']",0.9746926686181449,0,0,2
232,The Overlap Between Signal Transduction Pathways that Contribute to a Range of LMNA Laminopathies WP4879,0.7413252351369617,0.8017241379310345,0.23996873071887626,"['TGFB1', 'RUNX2']",0.9746926686181449,0,0,2
233,Complement system WP2806,0.7413252351369617,0.8017241379310345,0.23996873071887626,"['RPS19', 'CD59']",0.9746926686181449,0,0,2
234,Copper homeostasis WP3286,0.7413252351369617,0.8017241379310345,0.23996873071887626,"['COX17', 'ATOX1']",0.9746926686181449,0,0,2
235,Genotoxicity pathway WP4286,0.7413252351369617,0.8017241379310345,0.23996873071887626,"['RPS27', 'PHLDA3']",0.9746926686181449,0,0,2
236,IL-6 signaling pathway WP364,0.7413252351369617,0.8017241379310345,0.23996873071887626,"['PRKCD', 'VIP']",0.9746926686181449,0,0,2
237,Imatinib and Chronic Myeloid Leukemia WP3640,0.7413252351369617,0.8017241379310345,0.23996873071887626,"['KIT', 'PIM1']",0.9746926686181449,0,0,2
238,Lung fibrosis WP3624,0.7413252351369617,0.8017241379310345,0.23996873071887626,"['TGFB1', 'FGF1']",0.9746926686181449,0,0,2
239,MicroRNAs in cardiomyocyte hypertrophy WP1544,0.7413252351369617,0.8017241379310345,0.23996873071887626,"['TGFB1', 'FGFR2']",0.9746926686181449,0,0,2
240,Nucleotide Excision Repair WP4753,0.7413252351369617,0.8017241379310345,0.23996873071887626,"['POLE4', 'PCNA']",0.9746926686181449,0,0,2
241,p53 transcriptional gene network WP4963,0.7413252351369617,0.8017241379310345,0.23996873071887626,"['CCNG1', 'BAX']",0.9746926686181449,0,0,2
242,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.7413252351369617,0.8017241379310345,0.23996873071887626,"['BAX', 'ANGPTL1']",0.9746926686181449,0,0,2
243,Vitamin D Receptor Pathway WP2877,0.7443863368228216,0.8008658008658008,0.23641166738084854,"['SFRP1', 'TGFB1', 'IGFBP5', 'CDKN2A', 'CYP3A5']",0.9746926686181449,0,0,5
244,Myometrial relaxation and contraction pathways WP289,0.7443863368228216,0.8008658008658008,0.23641166738084854,"['IGFBP5', 'RGS16', 'PRKCD', 'CRH', 'PRKD1']",0.9746926686181449,0,0,5
245,Senescence and Autophagy in Cancer WP615,0.7563780865018103,0.8002894356005789,0.22345194516492,"['GABARAPL1', 'TGFB1', 'MAP1LC3A', 'PCNA', 'IGFBP5', 'CDKN2A', 'GABARAP']",0.9746926686181449,0,0,7
246,Airway smooth muscle cell contraction WP4962,0.7664250043834985,0.8020086083213773,0.21334906850338145,['PPP1R14A'],0.9746926686181449,0,0,1
247,Alanine and aspartate metabolism WP106,0.7664250043834985,0.8020086083213773,0.21334906850338145,['GOT1'],0.9746926686181449,0,0,1
248,Alpha 6 Beta 4 signaling pathway WP244,0.7664250043834985,0.8020086083213773,0.21334906850338145,['PRKCD'],0.9746926686181449,0,0,1
249,Splicing factor NOVA regulated synaptic proteins WP4148,0.7664250043834985,0.8020086083213773,0.21334906850338145,['NTNG1'],0.9746926686181449,0,0,1
250,Cell migration and invasion through p75NTR WP4561,0.7664250043834985,0.8020086083213773,0.21334906850338145,['EFNB3'],0.9746926686181449,0,0,1
251,Vitamin B12 metabolism WP1533,0.7664250043834985,0.8020086083213773,0.21334906850338145,['APOE'],0.9746926686181449,0,0,1
252,Vitamin D-sensitive calcium signaling in depression WP4698,0.7664250043834985,0.8020086083213773,0.21334906850338145,['GPX4'],0.9746926686181449,0,0,1
253,Endothelin Pathways WP2197,0.7664250043834985,0.8020086083213773,0.21334906850338145,['NPY'],0.9746926686181449,0,0,1
254,Extracellular vesicles in the crosstalk of cardiac cells WP4300,0.7664250043834985,0.8020086083213773,0.21334906850338145,['CD81'],0.9746926686181449,0,0,1
255,FGF23 signaling in hypophosphatemic rickets and related disorders WP4790,0.7664250043834985,0.8020086083213773,0.21334906850338145,['FGFR2'],0.9746926686181449,0,0,1
256,Galanin receptor pathway WP4970,0.7664250043834985,0.8020086083213773,0.21334906850338145,['PRKCD'],0.9746926686181449,0,0,1
257,Gastric Cancer Network 2 WP2363,0.7664250043834985,0.8020086083213773,0.21334906850338145,['FANCI'],0.9746926686181449,0,0,1
258,Genes related to primary cilium development (based on CRISPR) WP4536,0.7664250043834985,0.8020086083213773,0.21334906850338145,['WDR34'],0.9746926686181449,0,0,1
259,Genes targeted by miRNAs in adipocytes WP1992,0.7664250043834985,0.8020086083213773,0.21334906850338145,['TMSB4X'],0.9746926686181449,0,0,1
260,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7664250043834985,0.8020086083213773,0.21334906850338145,['TGFB1'],0.9746926686181449,0,0,1
261,IL-3 signaling pathway WP286,0.7664250043834985,0.8020086083213773,0.21334906850338145,['TGFB1'],0.9746926686181449,0,0,1
262,IL-5 signaling pathway WP127,0.7664250043834985,0.8020086083213773,0.21334906850338145,['RPS6'],0.9746926686181449,0,0,1
263,Joubert Syndrome WP4656,0.7664250043834985,0.8020086083213773,0.21334906850338145,['KAT5'],0.9746926686181449,0,0,1
264,Kisspeptin/kisspeptin receptor system in the ovary WP4871,0.7664250043834985,0.8020086083213773,0.21334906850338145,['PRKCD'],0.9746926686181449,0,0,1
265,Mammalian disorder of sexual development WP4842,0.7664250043834985,0.8020086083213773,0.21334906850338145,['FGFR2'],0.9746926686181449,0,0,1
266,Matrix Metalloproteinases WP129,0.7664250043834985,0.8020086083213773,0.21334906850338145,['MMP16'],0.9746926686181449,0,0,1
267,Melatonin metabolism and effects WP3298,0.7664250043834985,0.8020086083213773,0.21334906850338145,['APOE'],0.9746926686181449,0,0,1
268,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.7664250043834985,0.8020086083213773,0.21334906850338145,['B3GALT2'],0.9746926686181449,0,0,1
269,Neural Crest Cell Migration during Development WP4564,0.7664250043834985,0.8020086083213773,0.21334906850338145,['EPHB3'],0.9746926686181449,0,0,1
270,Neural Crest Cell Migration in Cancer WP4565,0.7664250043834985,0.8020086083213773,0.21334906850338145,['EPHB3'],0.9746926686181449,0,0,1
271,Notch Signaling Pathway Netpath WP61,0.7664250043834985,0.8020086083213773,0.21334906850338145,['MAML2'],0.9746926686181449,0,0,1
272,Nuclear receptors WP170,0.7664250043834985,0.8020086083213773,0.21334906850338145,['NR2F2'],0.9746926686181449,0,0,1
273,Omega-9 FA synthesis WP4724,0.7664250043834985,0.8020086083213773,0.21334906850338145,['ACOT2'],0.9746926686181449,0,0,1
274,Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling WP3612,0.7664250043834985,0.8020086083213773,0.21334906850338145,['GSTP1'],0.9746926686181449,0,0,1
275,Pre-implantation embryo WP3527,0.7664250043834985,0.8020086083213773,0.21334906850338145,['DDIT3'],0.9746926686181449,0,0,1
276,Prolactin Signaling Pathway WP2037,0.7664250043834985,0.8020086083213773,0.21334906850338145,['RPS6'],0.9746926686181449,0,0,1
277,NRF2 pathway WP2884,0.800835345310743,0.7383281458425968,0.16398261803079045,"['HSP90AA1', 'TGFB1', 'GSTP1', 'SLC39A11', 'SLC39A7', 'FTL']",0.9844487945602357,0,0,6
278,Ras signaling WP4223,0.8009117305841251,0.7114953570284982,0.15795519731988658,"['RASGRF2', 'KIT', 'PLD1', 'FGFR2']",0.9844487945602357,0,0,4
279,DNA damage response (only ATM dependent) WP710,0.8061291250992996,0.6863309352517986,0.14791210260684493,"['TGFB1', 'CDKN2A', 'BAX']",0.9844487945602357,0,0,3
280,Ebola Virus Pathway on Host WP4217,0.8061291250992996,0.6863309352517986,0.14791210260684493,"['VPS4A', 'HLA-B', 'MERTK']",0.9844487945602357,0,0,3
281,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.8061291250992996,0.6863309352517986,0.14791210260684493,"['SFRP1', 'CDK6', 'ROR2']",0.9844487945602357,0,0,3
282,Pathways Regulating Hippo Signaling WP4540,0.8061291250992996,0.6863309352517986,0.14791210260684493,"['PRKCD', 'KIT', 'FGFR2']",0.9844487945602357,0,0,3
283,DNA IR-damage and cellular response via ATR WP4016,0.8199051042528405,0.6408045977011494,0.1272424363303899,"['FANCI', 'PCNA']",0.9844487945602357,0,0,2
284,Leptin signaling pathway WP2034,0.8199051042528405,0.6408045977011494,0.1272424363303899,"['RPS6', 'BAX']",0.9844487945602357,0,0,2
285,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.8199051042528405,0.6408045977011494,0.1272424363303899,"['IFI27L2', 'PRKCD']",0.9844487945602357,0,0,2
286,Oxysterols derived from cholesterol WP4545,0.8199051042528405,0.6408045977011494,0.1272424363303899,"['EPHX2', 'ACOT2']",0.9844487945602357,0,0,2
287,Photodynamic therapy-induced unfolded protein response WP3613,0.8199051042528405,0.6408045977011494,0.1272424363303899,"['DDIT3', 'DNAJB9']",0.9844487945602357,0,0,2
288,Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway WP3670,0.856251221879535,0.5341941654710665,0.0829023737418638,['TGFB1'],0.9844487945602357,0,0,1
289,Angiogenesis WP1539,0.856251221879535,0.5341941654710665,0.0829023737418638,['FGFR2'],0.9844487945602357,0,0,1
290,Target Of Rapamycin (TOR) Signaling WP1471,0.856251221879535,0.5341941654710665,0.0829023737418638,['RRAGA'],0.9844487945602357,0,0,1
291,BDNF-TrkB Signaling WP3676,0.856251221879535,0.5341941654710665,0.0829023737418638,['TRPC3'],0.9844487945602357,0,0,1
292,Canonical and non-canonical Notch signaling WP3845,0.856251221879535,0.5341941654710665,0.0829023737418638,['MAML2'],0.9844487945602357,0,0,1
293,Envelope proteins and their potential roles in EDMD physiopathology WP4535,0.856251221879535,0.5341941654710665,0.0829023737418638,['TGFB1'],0.9844487945602357,0,0,1
294,Gastric Cancer Network 1 WP2361,0.856251221879535,0.5341941654710665,0.0829023737418638,['SMOC2'],0.9844487945602357,0,0,1
295,Glycogen Synthesis and Degradation WP500,0.856251221879535,0.5341941654710665,0.0829023737418638,['PHKG1'],0.9844487945602357,0,0,1
296,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.856251221879535,0.5341941654710665,0.0829023737418638,['RUNX2'],0.9844487945602357,0,0,1
297,IL-2 signaling pathway WP49,0.856251221879535,0.5341941654710665,0.0829023737418638,['RPS6'],0.9844487945602357,0,0,1
298,Integrated Cancer Pathway WP1971,0.856251221879535,0.5341941654710665,0.0829023737418638,['BAX'],0.9844487945602357,0,0,1
299,Mesodermal commitment pathway WP2857,0.856251221879535,0.5341941654710665,0.0829023737418638,['RPL38'],0.9844487945602357,0,0,1
300,miR-509-3p alteration of YAP1/ECM axis WP3967,0.856251221879535,0.5341941654710665,0.0829023737418638,['COL5A1'],0.9844487945602357,0,0,1
301,"Oligodendrocyte specification and differentiation, leading to myelin components for CNS WP4304",0.856251221879535,0.5341941654710665,0.0829023737418638,['OMG'],0.9844487945602357,0,0,1
302,Ovarian infertility WP34,0.856251221879535,0.5341941654710665,0.0829023737418638,['INHA'],0.9844487945602357,0,0,1
303,p38 MAPK Signaling Pathway WP400,0.856251221879535,0.5341941654710665,0.0829023737418638,['DDIT3'],0.9844487945602357,0,0,1
304,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.856251221879535,0.5341941654710665,0.0829023737418638,['BAX'],0.9844487945602357,0,0,1
305,Hippo-Merlin Signaling Dysregulation WP4541,0.8590226718573247,0.6,0.09117597841888923,"['PPP1R14A', 'KIT', 'FGFR2']",0.9844487945602357,0,0,3
306,PI3K-Akt signaling pathway WP4172,0.8745462778522713,0.683599419448476,0.09163654778003844,"['HSP90AA1', 'CDK6', 'PDGFC', 'KIT', 'RPS6', 'VEGFB', 'SGK1', 'FGF1', 'FGFR2']",0.9844487945602357,0,0,9
307,B Cell Receptor Signaling Pathway WP23,0.8763486331892628,0.5335249042145593,0.07042063722114503,"['CD81', 'PRKCD']",0.9844487945602357,0,0,2
308,Wnt signaling pathway and pluripotency WP399,0.8763486331892628,0.5335249042145593,0.07042063722114503,"['PRKCD', 'PRKD1']",0.9844487945602357,0,0,2
309,Development of ureteric collection system WP5053,0.8763486331892628,0.5335249042145593,0.07042063722114503,"['GDF11', 'FGFR2']",0.9844487945602357,0,0,2
310,Monoamine GPCRs WP58,0.8763486331892628,0.5335249042145593,0.07042063722114503,"['HTR2C', 'HTR5A']",0.9844487945602357,0,0,2
311,Neural Crest Differentiation WP2064,0.8763486331892628,0.5335249042145593,0.07042063722114503,"['LHX2', 'FGFR2']",0.9844487945602357,0,0,2
312,Primary focal segmental glomerulosclerosis (FSGS) WP2572,0.8763486331892628,0.5335249042145593,0.07042063722114503,"['PCNA', 'TGFB1']",0.9844487945602357,0,0,2
313,"GPCRs, Class A Rhodopsin-like WP455",0.8778702925850534,0.638728323699422,0.08319846914180246,"['MC1R', 'P2RY14', 'HTR2C', 'HTR5A', 'MCHR1', 'HCRTR2']",0.9844487945602357,0,0,6
314,Calcium Regulation in the Cardiac Cell WP536,0.8882861499471418,0.5810846214304427,0.06883606695643561,"['RGS16', 'PRKCD', 'ATP1B2', 'PRKD1']",0.9878252655221674,0,0,4
315,Regulation of Actin Cytoskeleton WP51,0.8988058183066573,0.5328537170263788,0.056849238715156535,"['TMSB4X', 'FGF1', 'FGFR2']",0.9878252655221674,0,0,3
316,Statin inhibition of cholesterol production WP430,0.9115631057260146,0.40028694404591103,0.03706435119869813,['APOE'],0.9878252655221674,0,0,1
317,Unfolded protein response WP4925,0.9115631057260146,0.40028694404591103,0.03706435119869813,['DDIT3'],0.9878252655221674,0,0,1
318,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.9115631057260146,0.40028694404591103,0.03706435119869813,['TGFB1'],0.9878252655221674,0,0,1
319,Genes controlling nephrogenesis WP4823,0.9115631057260146,0.40028694404591103,0.03706435119869813,['FGFR2'],0.9878252655221674,0,0,1
320,Male infertility WP4673,0.9115631057260146,0.40028694404591103,0.03706435119869813,['TEX15'],0.9878252655221674,0,0,1
321,miRNA targets in ECM and membrane receptors WP2911,0.9115631057260146,0.40028694404591103,0.03706435119869813,['COL5A1'],0.9878252655221674,0,0,1
322,Regulation of Microtubule Cytoskeleton WP2038,0.9115631057260146,0.40028694404591103,0.03706435119869813,['PARD6A'],0.9878252655221674,0,0,1
323,Wnt signaling WP428,0.9160506195401099,0.45689655172413796,0.04006235930512467,"['SFRP1', 'ROR2']",0.9878252655221674,0,0,2
324,G Protein Signaling Pathways WP35,0.9160506195401099,0.45689655172413796,0.04006235930512467,"['PRKCD', 'PRKD1']",0.9878252655221674,0,0,2
325,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9160506195401099,0.45689655172413796,0.04006235930512467,"['SFRP1', 'ROR2']",0.9878252655221674,0,0,2
326,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9370015342250074,0.5965166908563135,0.03881555544130743,"['HSP90AA1', 'COL5A1', 'PIK3IP1', 'PDGFC', 'KIT', 'RPS6', 'VEGFB', 'FGF1', 'FGFR2']",0.9878252655221674,0,0,9
327,ESC Pluripotency Pathways WP3931,0.9435308705458526,0.3994252873563218,0.023217072352219925,"['FGF1', 'FGFR2']",0.9878252655221674,0,0,2
328,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.9435308705458526,0.3994252873563218,0.023217072352219925,"['PSMC5', 'STUB1']",0.9878252655221674,0,0,2
329,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.9456105105853226,0.3199426111908178,0.017892636042356292,['TMSB4X'],0.9878252655221674,0,0,1
330,Bladder cancer WP2828,0.9456105105853226,0.3199426111908178,0.017892636042356292,['CDKN2A'],0.9878252655221674,0,0,1
331,Thermogenesis WP4321,0.9456105105853226,0.3199426111908178,0.017892636042356292,['RPS6'],0.9878252655221674,0,0,1
332,Chemokine signaling pathway WP3929,0.9456105105853226,0.3199426111908178,0.017892636042356292,['PRKCD'],0.9878252655221674,0,0,1
333,DNA Replication WP466,0.9456105105853226,0.3199426111908178,0.017892636042356292,['PCNA'],0.9878252655221674,0,0,1
334,Folate Metabolism WP176,0.9456105105853226,0.3199426111908178,0.017892636042356292,['GPX4'],0.9878252655221674,0,0,1
335,MET in type 1 papillary renal cell carcinoma WP4205,0.9456105105853226,0.3199426111908178,0.017892636042356292,['RPL11'],0.9878252655221674,0,0,1
336,Phosphodiesterases in neuronal function WP4222,0.9456105105853226,0.3199426111908178,0.017892636042356292,['PDE3A'],0.9878252655221674,0,0,1
337,Nuclear Receptors Meta-Pathway WP2882,0.9489837402778116,0.5883936261843239,0.030810416751776953,"['PSMC5', 'HSP90AA1', 'TGFB1', 'GSTP1', 'SLC39A11', 'AIP', 'BAX', 'SLC39A7', 'CYP3A5', 'FTL']",0.9884073971439523,0,0,10
338,Adipogenesis WP236,0.9648255629745462,0.3985611510791367,0.014271660854581739,"['WWTR1', 'TGFB1', 'DDIT3']",0.9891049596161569,0,0,3
339,Circadian rhythm related genes WP3594,0.9648255629745462,0.3985611510791367,0.014271660854581739,"['CRH', 'RPS27A', 'HCRTR2']",0.9891049596161569,0,0,3
340,Insulin Signaling WP481,0.9648255629745462,0.3985611510791367,0.014271660854581739,"['PRKCD', 'SGK1', 'PFKM']",0.9891049596161569,0,0,3
341,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9665612568328827,0.2663797226207556,0.009059734800744223,['TGFB1'],0.9891049596161569,0,0,1
342,Glucocorticoid Receptor Pathway WP2880,0.9665612568328827,0.2663797226207556,0.009059734800744223,['HSP90AA1'],0.9891049596161569,0,0,1
343,"GPCRs, Other WP117",0.9665612568328827,0.2663797226207556,0.009059734800744223,['ACKR1'],0.9891049596161569,0,0,1
344,Oncostatin M Signaling Pathway WP2374,0.9750111543250385,0.31896551724137934,0.008071858668148413,"['PRKCD', 'RPS6']",0.992005591357811,0,0,2
345,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.9835269110897955,0.28970741901776387,0.004812121045257013,"['RPS6', 'PRKCD']",0.992005591357811,0,0,2
346,Ciliopathies WP4803,0.9835269110897955,0.28970741901776387,0.004812121045257013,"['CCDC65', 'WDR34']",0.992005591357811,0,0,2
347,Endochondral Ossification with Skeletal Dysplasias WP4808,0.9835269110897955,0.28970741901776387,0.004812121045257013,"['TGFB1', 'RUNX2']",0.992005591357811,0,0,2
348,Endochondral Ossification WP474,0.9835269110897955,0.28970741901776387,0.004812121045257013,"['TGFB1', 'RUNX2']",0.992005591357811,0,0,2
349,Cholesterol metabolism (includes both Bloch and Kandutsch-Russell pathways) WP4718,0.9980773760245769,0.19827586206896552,0.00038157685822367865,"['ACOT2', 'TM7SF2']",0.998205573492329,0,0,2
350,Focal Adhesion WP306,0.9980773760245769,0.19827586206896552,0.00038157685822367865,"['PDGFC', 'VEGFB']",0.998205573492329,0,0,2
351,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.998205573492329,0.1324725011956002,0.00023792570167591718,['SST'],0.998205573492329,0,0,1
